Brief: EQL Pharma Signs Memprex License With Partner For Benelux
02/07/2025 08:52
July 2 (Reuters) - EQL Pharma AB EQL.ST: MEMPREX (METHENAMINE HIPPURATE) LICENSE SIGNED WITH PARTNER GOODLIFE SPECIALTY BV FOR BENELUX SUBJECT TO REACHING AGREED SALES, PARTNER TO PAY SIX-FIGURE SUM IN EUR SPREAD OVER SIX MILESTONES Source text: ID:nWkr38c9KB Further company coverage: EQL.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))